Valvular Regurgitation Treatment Device
Valvular regurgitation in patients with progressive heart failure
Pre-clinicalActive
Key Facts
Indication
Valvular regurgitation in patients with progressive heart failure
Phase
Pre-clinical
Status
Active
Company
About ConKay Medical Systems
ConKay Medical Systems is a private, early-stage medical device innovator targeting the significant unmet need of valvular regurgitation within the heart failure population. Founded in 2019, the company has gained recognition through programs like MedTech Innovator and UCSF Rosenman Innovator, indicating validation of its potential. Operating in the pre-revenue stage, ConKay is actively fundraising for its Series A round to advance its technology pipeline. The company's vision centers on creating impactful cardiovascular technologies to improve patient outcomes.
View full company profile